Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Effects of halothane on ganglionic discharges.

D Christ

    The Journal of Pharmacology and Experimental Therapeutics
    |February 1, 1977
    PubMed
    Summary

    This study investigated how the anesthetic halothane affects nerve signal transmission in hamster stellate ganglia. Researchers found that halothane interferes with nicotinic signaling and reduces neurotransmitter release during high-frequency stimulation, while leaving muscarinic signaling pathways largely unaffected.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Systematic Implementation of Effective Quality Assurance Processes for the Assessment of Radiation Target Volumes in Head and Neck Cancer.

    Practical radiation oncology·2024
    Same author

    Anaphylactic shock after sensitization to gelatin.

    British journal of anaesthesia·2011
    Same author

    Aggregation, stability, and formulation of human antibody therapeutics.

    Advances in protein chemistry and structural biology·2011
    Same author

    [Improvised closed suction drainage for surgery in precarious situation: "the khmeredon"].

    Journal de chirurgie·2009
    Same author

    [The pre-operative visit. A role for allied health personnel in oncologic surgery].

    Journal de chirurgie·2007
    Same author

    Design and synthesis of a series of (2R)-N(4)-hydroxy-2-(3-hydroxybenzyl)-N(1)- [(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]butanediamide derivatives as potent, selective, and orally bioavailable aggrecanase inhibitors.

    Journal of medicinal chemistry·2001

    Area of Science:

    • Neuropharmacology research within the field of halothane mechanisms
    • Autonomic nervous system physiology studies

    Background:

    No prior work had resolved the specific inhibitory actions of inhaled anesthetics on peripheral autonomic ganglia. That uncertainty drove researchers to investigate how volatile agents alter synaptic transmission. Prior research has shown that general anesthetics often disrupt neurotransmitter signaling pathways. However, the precise molecular targets within ganglionic structures remained poorly defined. This gap motivated a detailed examination of how specific chemical agents modify electrical output. Previous studies focused primarily on central nervous system targets rather than peripheral autonomic nodes. Investigators required a controlled model to isolate the effects of these agents on synaptic junctions. This study addresses the need for clarity regarding how anesthetic concentrations modulate ganglionic excitability.

    Purpose Of The Study:

    The aim of this study was to characterize the effects of halothane on ganglionic transmission within the peripheral nervous system. Researchers sought to determine how this volatile anesthetic modulates synaptic signaling in the stellate ganglion. This investigation addressed the specific problem of identifying the cellular sites of action for general anesthetics. The motivation for this work stemmed from the need to understand how these agents alter autonomic output. No prior work had resolved whether the anesthetic acts on the presynaptic or postsynaptic components of the synapse. Investigators designed experiments to differentiate between nicotinic and muscarinic receptor-mediated pathways. They intended to clarify the concentration-dependent inhibitory profiles of the drug on various nerve discharges. This study provides a detailed analysis of how synaptic transmission is compromised by anesthetic exposure.

    Keywords:
    synaptic transmissionnicotinic receptorsmuscarinic signalinganesthetic pharmacologystellate ganglion

    Frequently Asked Questions

    The researchers propose that the anesthetic acts at two distinct sites. It suppresses postsynaptic responses to nicotinic acetylcholine receptor activation and simultaneously reduces neurotransmitter release from presynaptic nerve endings during high-frequency stimulation.

    The study utilized 1,1-dimethyl-4-phenylpiperazinium as a selective nicotinic agonist to probe receptor-mediated responses. In contrast, the researchers employed McN-A-343 to specifically evaluate the muscarinic signaling pathways within the isolated ganglion.

    The stellate ganglion was isolated from hamsters to allow for precise extracellular recording of postganglionic nerve potentials. This preparation is necessary to isolate the synaptic junction from central nervous system influences and systemic circulatory factors.

    Related Experiment Videos

    Main Methods:

    The review approach involved recording extracellular potentials from the isolated stellate ganglion of hamsters. Investigators applied preganglionic stimuli at a frequency of 0.2 Hz to evoke baseline nerve responses. The team introduced the anesthetic at concentrations exceeding 0.1 mM to observe changes in potential amplitude. Researchers used 1,1-dimethyl-4-phenylpiperazinium to trigger nicotinic-specific discharges within the nerve preparation. They also employed repetitive stimulation at 30 Hz for five seconds to induce asynchronous activity. Atropine served as a tool to suppress muscarinic-mediated discharges during these high-frequency trials. The study compared these results against responses elicited by the muscarinic agonist McN-A-343. This systematic testing allowed for the differentiation of anesthetic impacts across distinct synaptic signaling pathways.

    Main Results:

    Key findings from the literature indicate that the anesthetic significantly decreases potentials evoked by low-frequency preganglionic stimulation at concentrations above 0.1 mM. The agent effectively blocked discharges elicited by the nicotinic agonist 1,1-dimethyl-4-phenylpiperazinium. Furthermore, the drug suppressed discharges triggered by the nicotinic actions of exogenous acetylcholine. Repetitive stimulation protocols revealed that the anesthetic inhibited asynchronous discharges at concentrations similar to those affecting baseline compound action potentials. The study demonstrated that the drug had no measurable effect on discharges elicited by the muscarinic agonist McN-A-343. Similarly, the agent failed to alter discharges resulting from the muscarinic actions of acetylcholine. These observations suggest that the anesthetic selectively targets nicotinic pathways while leaving muscarinic mechanisms intact. The data confirm that the drug acts through both postsynaptic and presynaptic inhibitory processes.

    Conclusions:

    The authors propose that this anesthetic exerts inhibitory effects through two distinct mechanisms within the stellate ganglion. Synthesis and implications suggest that the agent primarily suppresses postsynaptic responses triggered by nicotinic receptor activation. Furthermore, the evidence indicates that the drug likely reduces neurotransmitter release from presynaptic terminals during rapid stimulation. These findings highlight a dual-site action profile for the anesthetic in peripheral autonomic tissues. The researchers note that muscarinic signaling pathways remain resistant to these inhibitory effects under the tested conditions. This synthesis clarifies why certain autonomic responses persist despite the presence of the anesthetic. The results provide a framework for understanding how volatile agents alter ganglionic transmission. Future investigations might explore whether these mechanisms apply to other autonomic ganglia across different species.

    Extracellular potentials recorded from the postganglionic nerve served as the primary data type. These electrical signals allowed the researchers to quantify the inhibitory impact of the anesthetic on synaptic output under various stimulation protocols.

    The researchers measured the suppression of compound action potentials elicited by 0.2 Hz preganglionic stimulation. They also observed the inhibition of asynchronous discharges triggered by repetitive 30 Hz stimulation in the presence of nicotine or hexamethonium.

    The authors suggest that the anesthetic selectively impairs nicotinic transmission while sparing muscarinic pathways. This implies that the drug's impact on autonomic function is highly dependent on the specific receptor subtypes involved in the synaptic transmission process.